Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.
Smith DM, Douglas MP, Aquilante CL, Deverka PA, Devine B, Dunnenberger HM, Empey PE, Hertz DL, Monte AA, Moyer AM, Patel JN, Pratt VM, Saulsberry L, Scott SA, Voora D, Woodahl EL, Whirl-Carrillo M, Oni-Orisan A; Pharmacogenomics Global Research Network (PGRN) Publications Committee.
Smith DM, et al.
Clin Pharmacol Ther. 2025 Oct;118(4):778-789. doi: 10.1002/cpt.3736. Epub 2025 Jun 4.
Clin Pharmacol Ther. 2025.
PMID: 40468601
Free PMC article.
Review.
This narrative review used authors' expertise and experience to identify and describe current barriers to pharmacogenetic implementation across seven domains in the United States: equity and inclusion; guidelines and supporting evidence; regulatory agency oversight; payer cove …
This narrative review used authors' expertise and experience to identify and describe current barriers to pharmacogenetic implementation acr …